应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GMTX Gemini Therapeutics, Inc.
已收盘 05-02 16:00:00 EDT
1.35
+0.00
0.00%
最高
1.35
最低
1.35
成交量
0.00
今开
1.35
昨收
1.35
日振幅
0.00%
总市值
584.93万
流通市值
153.72万
总股本
433.28万
成交额
0.00
换手率
0.00%
流通股本
113.86万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Gemini Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Gemini Therapeutics, Inc.于2020年6月25日在特拉华州注册成立。Gemini Therapeutics是一家临床阶段的精准医疗公司,开发新型治疗化合物来治疗基因定义的年龄相关性黄斑变性。Gemini 的主要候选药物GEM103是人类补体因子H蛋白(CFH)的重组形式,旨在解决AMD患者的补体过度活跃和恢复视网膜健康。
发行价格:
--
{"stockData":{"symbol":"GMTX","market":"US","secType":"STK","nameCN":"Gemini Therapeutics, Inc.","latestPrice":1.35,"timestamp":1714680000000,"preClose":1.35,"halted":8,"volume":0,"delay":0,"floatShares":1138649,"shares":4332831,"eps":-10.04677,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"05-02 16:00:00 EDT","open":1.35,"high":1.35,"low":1.35,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-10.04677,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714723200000},"symbolChange":{"newSymbol":"IRON","executeDate":"2022-12-30"},"adr":0,"listingDate":1597204800000,"adjPreClose":1.35,"volumeRatio":0},"requestUrl":"/m/hq/s/GMTX","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.geminitherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.9},{"period":"1month","weight":-0.9},{"period":"3month","weight":-0.9},{"period":"6month","weight":-0.9},{"period":"1year","weight":-0.9},{"period":"ytd","weight":-0.9}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gemini Therapeutics, Inc.于2020年6月25日在特拉华州注册成立。Gemini Therapeutics是一家临床阶段的精准医疗公司,开发新型治疗化合物来治疗基因定义的年龄相关性黄斑变性。Gemini 的主要候选药物GEM103是人类补体因子H蛋白(CFH)的重组形式,旨在解决AMD患者的补体过度活跃和恢复视网膜健康。","exchange":"NASDAQ","name":"Gemini Therapeutics, Inc.","nameEN":"Gemini Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gemini Therapeutics, Inc.(GMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gemini Therapeutics, Inc.(GMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gemini Therapeutics, Inc.,GMTX,Gemini Therapeutics, Inc.股票,Gemini Therapeutics, Inc.股票老虎,Gemini Therapeutics, Inc.股票老虎国际,Gemini Therapeutics, Inc.行情,Gemini Therapeutics, Inc.股票行情,Gemini Therapeutics, Inc.股价,Gemini Therapeutics, Inc.股市,Gemini Therapeutics, Inc.股票价格,Gemini Therapeutics, Inc.股票交易,Gemini Therapeutics, Inc.股票购买,Gemini Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gemini Therapeutics, Inc.(GMTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gemini Therapeutics, Inc.(GMTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}